Board approval for the Company to change its name to “Golden Meditech Holdings Limited”, to better reflect the Group’s diversity and depth in China’s healthcare industry
Launched China’s first third-party medical insurance information management and back-office administration BPO joint-venture, GM-Medicare Management (China) Company Limited, with two leading US-based health maintenance organisations (HMOs), SynerMed and EHS
2009:
New cord blood storage facility, currently the largest cord blood storage facility in the world in terms of capacity and daily processing volume, commenced operation in Beijing
Transferred listing from the Growth Enterprise Market onto the Main Board of the Hong Kong Stock Exchange in June 2009 (801.HK)
Completed the acquisition and obtained the first ever nationwide hospital management licensed to a wholly-owned foreign entity. Subsequently completed the private equity financing for hospital management operations with a pre-money valuation of US$210 million valuation
China Cord Blood successfully listed on New York Stock Exchange (CO.US)
FunTalk China Holdings (“FunTalk”, FTLK.US) successfully listed on NASDAQ
Entered into negotiation with Fenwal Inc. for the formation of a joint-venture operation targeting the China market
2008:
Obtained SFDA approval for Plasma Exchange System and Accelerated Thermostatic Infusion Pump
New cord blood storage facilities commenced operation in Guangdong Province
2007:
Successfully completed second round of private placement for the cord blood banking business with a pre-money valuation at US$200 million
Expansion of cord blood banking business into Guangdong Province
FunTalk China successfully completed a US$90 million private placement with a post-money valuation of US$270 million
2006:
Successfully completed a private placement for the cord blood banking business with a pre-money valuation at US$100 million
Strategic investment in Pypo Technology (later became “FunTalk China Holdings Limited”)
2004:
Strategic investment in Union China National Medical Equipment Corporation Limited (“UCMC”) under the Sinopharm Group.
UCMC is China’s first and largest sino-foreign medical devices distribution joint venture
2003:
Strategic investment in and commencement of cord blood bank operation in Beijing
2002:
Medical devices production facility in Beijing obtained GMP certification and commenced production
2001:
Listed on the Growth Enterprise Market (“GEM”) of The Stock Exchange of Hong Kong Limited (8180.HK)
2000:
Golden Meditech became the first ABRS (Autologous Blood Recovery System) manufacturer to obtain State Food and Drug Administration (SFDA) approval
2010:
